← Leaderboards
Alan Richard Tall
Columbia University Health Sciences
$42,229,886
Attributed
$42,229,886
Total exposure
28
Grants
19
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $6.3M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$71,514,836 · 31
By mechanism
P01$28,809,698 · 10
R01$26,889,671 · 11
P50$14,759,709 · 6
R37$1,020,758 · 1
R13$35,000 · 3
Top collaborators
No co-investigators on record.
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Ira A Tabas$44,847,082
- Muredach P Reilly$136,077,018
- Henry N Ginsberg$119,772,603
- Huize Pan$794,298
- Arif Yurdagul$3,430,427
Others in their field
Top investigators on “Atherosclerosis”
- Eric A Boerwinkle · University Of Texas Hlth Sci Ctr Houston$63,519,256
- Josef Coresh · New York University School Of Medicine$60,445,875
- Daniel James Rader · University Of Pennsylvania$50,278,074
- Howard N Hodis · University Of Southern California$49,943,399
- Gary K Owens · University Of Virginia$42,472,259
- Peter O Kohler · Oregon Health And Science University$38,512,009
Research focus
AtherosclerosisMacrophageCholesterolMediatingHigh Density LipoproteinsLinkArterial Fatty StreakAtherogenesisCellsGenesLesionPathway InteractionsSignal TransductionPlasmaLow-Density LipoproteinsIn VivoAreaInflammatoryMutationKnock-DownInflammationKnock-OutLipidsMouse Model
Grant awards (118)
Cellular and Molecular Mechanisms of Atherosclerosis$2,503,865
P01 · FY2025 · HL · contact PI
Clonal hematopoiesis, inflammasomes and atherosclerosis$775,384
R01 · FY2025 · HL · contact PI
Inflammatory crosstalk between macrophages and stromal cells in clonal hematopoiesis$631,700
P01 · FY2025 · HL · contact PI
Cholesterol efflux, CHIP and inflammasome activation$616,875
R01 · FY2025 · HL · contact PI
Administrative Core$188,069
P01 · FY2025 · HL · contact PI
Cellular and Molecular Mechanisms of Atherosclerosis$2,070,048
P01 · FY2024 · HL · contact PI
Cholesterol efflux, CHIP and inflammasome activation$604,538
R01 · FY2024 · HL · contact PI
Clonal hematopoiesis, inflammasomes and atherosclerosis$533,262
R01 · FY2024 · HL · contact PI
Administrative Core$189,176
P01 · FY2024 · HL · contact PI
Inflammatory crosstalk between macrophages and stromal cells in clonal hematopoiesis$186,836
P01 · FY2024 · HL · contact PI
New therapeutic approaches in clonal hematopoiesis and atherosclerosis$694,718
R01 · FY2023 · HL · contact PI
Cholesterol efflux, CHIP and inflammasome activation$616,875
R01 · FY2023 · HL · contact PI
Clonal hematopoiesis, inflammasomes and atherosclerosis$544,145
R01 · FY2023 · HL · contact PI
TTC39B in obesity and atherosclerosis$544,861
P01 · FY2022 · HL · contact PI
Clonal hematopoiesis, inflammasomes and atherosclerosis$544,145
R01 · FY2022 · HL · contact PI
ABCA1/G1 and LXRs in Atherogenesis$502,605
R01 · FY2022 · HL · contact PI
TTC39B in Metabolism$466,920
R01 · FY2022 · HL · contact PI
TTC39B in obesity and atherosclerosis$544,861
P01 · FY2021 · HL · contact PI
Clonal hematopoiesis, inflammasomes and atherosclerosis$544,145
R01 · FY2021 · HL · contact PI
ABCA1/G1 and LXRs in Atherogenesis$510,373
R01 · FY2021 · HL · contact PI
TTC39B in Metabolism$473,466
R01 · FY2021 · HL · contact PI
TTC39B in obesity and atherosclerosis$544,861
P01 · FY2020 · HL · contact PI
ABCA1/G1 and LXRs in Atherogenesis$517,914
R01 · FY2020 · HL · contact PI
Mechanisms linking LNK genetic variation to atherothrombosis$509,986
R01 · FY2020 · HL · contact PI
TTC39B in Metabolism$479,823
R01 · FY2020 · HL · contact PI
TTC39B in obesity and atherosclerosis$544,861
P01 · FY2019 · HL · contact PI
ABCA1/G1 and LXRs in Atherogenesis$525,236
R01 · FY2019 · HL · contact PI
Mechanisms linking LNK genetic variation to atherothrombosis$509,986
R01 · FY2019 · HL · contact PI
TTC39B in Metabolism$486,000
R01 · FY2019 · HL · contact PI
TTC39B in obesity and atherosclerosis$544,861
P01 · FY2018 · HL · contact PI
Mechanisms linking LNK genetic variation to atherothrombosis$509,986
R01 · FY2018 · HL · contact PI
ABCA1/G1 and LXRs in Atherogenesis$403,760
R01 · FY2018 · HL · contact PI
TTC39B in Metabolism$400,000
R01 · FY2018 · HL · contact PI
Hyperinsulinemia, mTOR Activity and Plasma Lipoproteins$538,135
P01 · FY2017 · HL · contact PI
Mechanisms linking LNK genetic variation to atherothrombosis$509,986
R01 · FY2017 · HL · contact PI
ABCA1/G1 and LXRs in Atherogenesis$403,760
R01 · FY2017 · HL · contact PI
TTC39B in Metabolism$400,000
R01 · FY2017 · HL · contact PI
Hyperinsulinemia, mTOR Activity and Plasma Lipoproteins$538,135
P01 · FY2016 · HL · contact PI
ABCA1/G1 and LXRs in Atherogenesis$403,760
R01 · FY2016 · HL · contact PI
TTC39B in Metabolism$400,000
R01 · FY2016 · HL · contact PI
Hyperinsulinemia, mTOR Activity and Plasma Lipoproteins$530,063
P01 · FY2015 · HL · contact PI
ABCA1/G1 and LXRs in Atherogenesis$403,760
R01 · FY2015 · HL · contact PI
TTC39B in Metabolism$400,000
R01 · FY2015 · HL · contact PI
Hyperinsulinemia, mTOR Activity and Plasma Lipoproteins$527,374
P01 · FY2014 · HL · contact PI
ABCA1/ABCG1 in myeloid populations and atherogenesis$394,450
R01 · FY2014 · HL · contact PI
ABCG1 and endothelial function$394,450
R01 · FY2014 · HL · contact PI
ABCG1 and endothelial function$383,180
R01 · FY2013 · HL · contact PI
ABCA1/ABCG1 in myeloid populations and atherogenesis$383,180
R01 · FY2013 · HL · contact PI
Hyperinsulinemia, mTOR Activity and Plasma Lipoproteins$151,835
P01 · FY2013 · HL · contact PI
ABCG1 and endothelial function$402,500
R01 · FY2012 · HL · contact PI
ABCA1/ABCG1 in myeloid populations and atherogenesis$402,500
R01 · FY2012 · HL · contact PI
Hyperinsulinemia, mTOR activity and plasma lipoproteins$386,299
R01 · FY2012 · HL · contact PI
Insulin Signaling, Lipoproteins and Atherosclerosis$541,497
P01 · FY2011 · HL · contact PI
ABCA1/ABCG1 in myeloid populations and atherogenesis$402,500
R01 · FY2011 · HL · contact PI
ABCG1 and endothelial function$402,500
R01 · FY2011 · HL · contact PI
New Genes and Pathways Involved in Atherosclerosis$2,419,961
P01 · FY2010 · HL · contact PI
Novel Pathways of Cellular Cholesterol Efflux$571,784
P01 · FY2010 · HL · contact PI
Insulin Signaling, Lipoproteins and Atherosclerosis$541,497
P01 · FY2010 · HL · contact PI
Macrophage Foam Cells, Cathepsins and Cholesterol Efflux$518,888
R01 · FY2010 · HL · contact PI
New Genes and Pathways Involved in Atherosclerosis$2,362,079
P01 · FY2009 · HL · contact PI
Novel Pathways of Cellular Cholesterol Efflux$566,877
P01 · FY2009 · HL · contact PI
Insulin Signaling, Lipoproteins and Atherosclerosis$541,497
P01 · FY2009 · HL · contact PI
Macrophage Foam Cells, Cathepsins and Cholesterol Efflux$529,480
R01 · FY2009 · HL · contact PI
ABCA7: Cellular Functions and Role in Atherosclerosis$387,000
R01 · FY2009 · HL · contact PI
New Genes and Pathways Involved in Atherosclerosis$2,259,772
P01 · FY2008 · HL · contact PI
Insulin Signaling, Lipoproteins and Atherosclerosis$541,497
P01 · FY2008 · HL · contact PI
Novel Pathways of Cellular Cholesterol Efflux$541,489
P01 · FY2008 · HL · contact PI
Macrophage Foam Cells, Cathepsins and Cholesterol Efflux$529,480
R01 · FY2008 · HL · contact PI
ABCA7: Cellular Functions and Role in Atherosclerosis$386,435
R01 · FY2008 · HL · contact PI
New Genes and Pathways Involved in Atherosclerosis$2,251,326
P01 · FY2007 · HL · contact PI
Insulin Signaling, Lipoproteins and Atherosclerosis$552,549
P01 · FY2007 · HL · contact PI
Novel Pathways of Cellular Cholesterol Efflux$538,613
P01 · FY2007 · HL · contact PI
Macrophage Foam Cells, Cathepsins and Cholesterol Efflux$529,480
R01 · FY2007 · HL · contact PI
ABCA7: Cellular Functions and Role in Atherosclerosis$385,907
R01 · FY2007 · HL · contact PI
Kern Aspen Lipid Conference$10,000
R13 · FY2007 · HL · contact PI
New Genes and Pathways Involved in Atherosclerosis$2,285,755
P01 · FY2006 · HL · contact PI
The Arterial Wall and Atherogenesis in Mice and Humans$1,986,559
P50 · FY2006 · HL · contact PI
Cholesterol Efflux, Foam Cell Formation and Diabetes$585,579
R01 · FY2006 · HL · contact PI
Novel Pathways of Cellular Cholesterol Efflux$482,850
P01 · FY2006 · HL · contact PI
ABCA7: Cellular Functions and Role in Atherosclerosis$396,925
R01 · FY2006 · HL · contact PI
Molecular and Cellular Mechanisms of Chloesterol Efflux$291,142
P50 · FY2006 · HL · contact PI
Administrative Core$226,397
P01 · FY2006 · HL · contact PI
Core C--$94,755
P50 · FY2006 · HL · contact PI
The Arterial Wall and Atherogenesis in Mice and Humans$1,984,094
P50 · FY2005 · HL
Cholesterol Efflux, Foam Cell Formation and Diabetes$585,707
R01 · FY2005 · HL
Novel Pathways of Cellular Cholesterol Efflux$402,500
R01 · FY2005 · HL
Scavenger Receptor B1 and HDL Metabolism$298,375
R01 · FY2005 · HL
Molecular and Cellular Mechanisms of Chloesterol Efflux$283,843
P50 · FY2005 · HL
Core C--$91,995
P50 · FY2005 · HL
The Arterial Wall and Atherogenesis in Mice and Humans$1,935,289
P50 · FY2004 · HL
Cholesterol Efflux, Foam Cell Formation and Diabetes$572,149
R01 · FY2004 · HL
Scavenger Receptor B1 and HDL Metabolism$298,375
R01 · FY2004 · HL
Molecular and Cellular Mechanisms of Chloesterol Efflux$276,758
P50 · FY2004 · HL
Core C--$89,316
P50 · FY2004 · HL
Core A-- Administrative Core$84,414
P50 · FY2004 · HL
The Arterial Wall and Atherogenesis in Mice and Humans$1,887,898
P50 · FY2003 · HL
Cholesterol Efflux, Foam Cell Formation and Diabetes$558,511
R01 · FY2003 · HL
Scavenger Receptor B1 and HDL Metabolism$298,375
R01 · FY2003 · HL
The Arterial Wall and Atherogenesis in Mice and Humans$1,857,765
P50 · FY2002 · HL
Cholesterol Efflux, Foam Cell Formation and Diabetes$542,242
R01 · FY2002 · HL
Scavenger Receptor B1 and HDL Metabolism$298,375
R01 · FY2002 · HL
Regulation and function of plasma lipid transfer proteins$268,239
P01 · FY2002 · HL
Core--Gene expression profiling$0
P50 · FY2002 · HL
Molecular and cellular mechanisms of cholesterol efflux$0
P50 · FY2002 · HL
ARTERIAL WALL AND ATHEROGENESIS$1,764,336
P50 · FY2001 · HL
STRUCTURE/FUNCTION OF HIGH DENSITY LIPOPROTEINS$516,451
R37 · FY2001 · HL
Scavenger Receptor B1 and HDL Metabolism$298,375
R01 · FY2001 · HL
Regulation and function of plasma lipid transfer proteins$268,239
P01 · FY2001 · HL
Gordon Research Conference on Atherosclerosis-2001-02$15,000
R13 · FY2001 · HL
CORE--MOLECULAR BIOLOGY$0
P50 · FY2001 · HL
CETP, HDL AND ATHEROGENESIS$0
P50 · FY2001 · HL
ARTERIAL WALL AND ATHEROGENESIS$1,716,203
P50 · FY2000 · HL
STRUCTURE/FUNCTION OF HIGH DENSITY LIPOPROTEINS$504,307
R37 · FY2000 · HL
Regulation and function of plasma lipid transfer proteins$268,239
P01 · FY2000 · HL
SCAVENGER RECEPTOR B1 AND HDL METABOLISM$244,546
R01 · FY2000 · HL
CORE--MOLECULAR BIOLOGY$207,671
P50 · FY2000 · HL
CETP, HDL AND ATHEROGENESIS$207,671
P50 · FY2000 · HL
2000 KERN ASPEN LIPID CONFERENCE$10,000
R13 · FY2000 · HL